scholarly journals Epidemiology of Antepartum Stillbirths in Austria—A Population-Based Study between 2008 and 2020

2021 ◽  
Vol 10 (24) ◽  
pp. 5828
Author(s):  
Dana Anaïs Muin ◽  
Hanns Helmer ◽  
Hermann Leitner ◽  
Sabrina Neururer

(1) Background: Across Europe, the incidence of antepartum stillbirth varies greatly, partly because of heterogeneous definitions regarding gestational weeks and differences in legislation. With this study, we sought to provide a comprehensive overview on the demographics of antepartum stillbirth in Austria, defined as non-iatrogenic fetal demise ≥22+0 gestational weeks (/40). (2) Methods: We conducted a population-based study on epidemiological characteristics of singleton antepartum stillbirth in Austria between January 2008 and December 2020. Data were derived from the validated Austrian Birth Registry. (3) Results: From January 2008 through December 2020, the antepartum stillbirth rate ≥20+0/40 was 3.10, ≥22+0/40 3.14, and ≥24+0/40 2.83 per 1000 births in Austria. The highest incidence was recorded in the federal states of Vienna, Styria, and Lower and Upper Austria, contributing to 71.9% of all stillbirths in the country. In the last decade, significant fluctuations in incidence were noted: from 2011 to 2012, the rate significantly declined from 3.40 to 3.07‰, whilst it significantly increased from 2.76 to 3.49‰ between 2019 and 2020. The median gestational age of antepartum stillbirth in Austria was 33+0 (27+2–37+4) weeks. Stillbirth rates ≤26/40 ranged from 164.98 to 334.18‰, whilst the lowest rates of 0.58–8.4‰ were observed ≥36/40. The main demographic risk factors were maternal obesity and low parity. (4) Conclusions: In Austria, the antepartum stillbirth rate has remained relatively stable at 2.83–3.10 per 1000 births for the last decade, despite a significant decline in 2012 and an increase in 2020.

2018 ◽  
Vol 187 (7) ◽  
pp. 1362-1369 ◽  
Author(s):  
Ai Kubo ◽  
Julianna Deardorff ◽  
Cecile A Laurent ◽  
Assiamira Ferrara ◽  
Louise C Greenspan ◽  
...  

2015 ◽  
Vol 44 (suppl_1) ◽  
pp. i192-i192
Author(s):  
M. S. Felisbino-Mendes ◽  
A. D. Moreira ◽  
G. Velasquez-Melendez

2020 ◽  
Author(s):  
Amir Almasi-Hashiani ◽  
Mohammad Ali Sahraian ◽  
Sharareh Eskandarieh

Abstract Background: The epidemiological characteristics of Multiple Sclerosis (MS) in various studies have been investigated and studies suggested that there is a different geographic disparity worldwide. The present study conducted to investigate the longitudinal prevalence of MS in Tehran, Iran. Methods: The population-based study was conducted in Tehran, the capital of Iran from 1999 to 2018 based on the annual report data through the Iranian MS Society (IMSS) registry system. The age-standardized and crude prevalence proportions were estimated by applicant of population data, established from the Statistical Centre of Iran. Results: Totally 21,580 MS cases were registered and included in the analysis. Out of them, 24.99% (5,393 cases) was male and 75.01% (16,187 cases) was female. The mean age of MS onset was 28.8 years (S.D: 8.7). The age standardized prevalence proportion (ASP) of MS ranged from 73.7 (95%CI: 72.1-75.2) in 2006 to 137.6 (95% CI: 135.7-139.5) per 100,000 in 2018. The MS ASP- was estimated 54.1 (95%CI: 53.6-54.6) among males and 174.5 (95%CI: 173.6-175.4) per 100,000 among females. The age standardized female to male ratio of MS in study period was 3.03. Conclusion: Our finding suggested that the prevalence of MS in Tehran province is relatively high and the disease occurrence is more common in the under-40 age group than in the older ones. As in the rest of the world, the prevalence of the MS was higher in women, and the female to male sex ratio was 3.03 in our study.


PLoS ONE ◽  
2019 ◽  
Vol 14 (7) ◽  
pp. e0219930 ◽  
Author(s):  
Kari Klungsøyr ◽  
Tone Irene Nordtveit ◽  
Trine Sand Kaastad ◽  
Sigrun Solberg ◽  
Ida Neergård Sletten ◽  
...  

Author(s):  
Chioma A. Ikedionwu ◽  
Deepa Dongarwar ◽  
Korede K. Yusuf ◽  
Sahra Ibrahimi ◽  
Abraham A. Salinas-Miranda ◽  
...  

Obesity Facts ◽  
2020 ◽  
Vol 13 (4) ◽  
pp. 333-348
Author(s):  
Roland Devlieger ◽  
Lieveke Ameye ◽  
Tinne Nuyts ◽  
Régine Goemaes ◽  
Annick Bogaerts

<b><i>Background and Objective:</i></b> Maternal obesity is an epidemic health problem that is aggravated by excessive gestational weight gain (GWG) and postpartum weight retention. Current US Institute of Medicine (now US National Academy of Medicine) guidelines (2009) for GWG need to be evaluated against the current rise in obesity in the general and pregnant population. We wanted to study the relation between GWG and pregnancy and birth outcomes and to relate this to the current recommendations for GWG. <b><i>Methods:</i></b> Population-based study. We performed an epidemiological analysis in a cohort of Belgian pregnant women with singleton live births at term (≥37 weeks) between 2009 and 2014 (<i>n</i> = 337,590). Logistic regression was used to determine the optimal GWG in relation to relevant pregnancy and birth outcomes. <b><i>Results:</i></b> The prevalence of maternal obesity significantly increased from 10.3% in 2009 to 11.4% in 2014. The mean (SD) body mass index at the start of the pregnancy significantly increased from 23.9 (4.5) in 2009 to 24.2 (4.6) in 2014. Excessive GWG was frequent, especially in overweight (56.8%) and obese (52.9%) pregnant women. In the logistic regression model, the amount of GWG associated with the lowest incidence of both large-for-gestational-age and small-for-gestational-age infants was 21 kg in underweight women, 14 kg in normal weight, 8 kg in overweight, 0 kg in obese class I, –4 kg in obese class II and –5 kg in obese class III. <b><i>Conclusion:</i></b> The prevalence of maternal obesity has risen in Belgium between 2009 and 2014. Current GWG guidelines, based on historic observational data, are probably too liberal for class II and III obese women in which better outcomes are being predicted for lower weight gain than recommended.


2020 ◽  
Author(s):  
Amir Almasi-Hashiani ◽  
Mohammad Ali Sahraian ◽  
Sharareh Eskandarieh

Abstract Background: The epidemiological characteristics of multiple sclerosis (MS) have been investigated in various studies, which have revealed that the prevalence of MS varies across countries. The present study was conducted to investigate the longitudinal prevalence of MS in Tehran, Iran. Methods: The present population-based study was conducted in Tehran, the capital of Iran from 1999 to 2018 based on the annual report data provided by the Iranian MS Society (IMSS) registry system. The age-standardized and crude prevalence were estimated using population data presented by the Statistical Centre of Iran. Results: A total of 21,580 MS cases were registered and included in the analysis. Among the participant patients, 24.99% (5,393) and 75.01% (16,187) of cases were male and female, respectively. The mean age of MS onset was 28.8 years (S.D: 8.7). The age-standardized prevalence (ASP) of MS increased from 73.7 (95%CI: 72.1-75.2) per 100,000 people in 2006 to 137.6 (95% CI: 135.7-139.5) per 100,000 people in 2018. The ASP of MS in 2018 was estimated to be 67.9 (95%CI: 66.0-69.8) and 207.3 (95%CI: 204.0-210.7) per 100,000 people among males and females, respectively. The age-standardized female-to-male ratio of MS ranged from 3.7 (in 2010) to 2.06 (in 2017). Conclusion: The findings of this study suggested that the prevalence of MS in Tehran province is relatively high, and the occurrence of the disease is more common in the age groups under 40 years as compared with older-aged groups. In line with reports provided for various regions of the world, the prevalence of MS was higher among women. Similarly, the findings of this study revealed that the female-to-male ratio was 2.14 in 2018.


Sign in / Sign up

Export Citation Format

Share Document